| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/02/2004 | US20040242593 Cannabinoid derivatives, methods of making, and use thereof |
| 12/02/2004 | US20040242592 2-Substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors |
| 12/02/2004 | US20040242591 phenyloxazolidinones derivatives that exhibit significantly greater antibacterial activity, than available with the present compounds against multiply resistant gram positive pathogens |
| 12/02/2004 | US20040242590 Pharmaceutical composition comprising gamma-butyrobetaine |
| 12/02/2004 | US20040242589 3-arylsulfonyl-7-piperzinyl-indoles-benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders |
| 12/02/2004 | US20040242588 alpha 2 adrenergic receptor agonist in a topical carrier; amount sufficient to decrease blood flow through the small arteries or arterioles of the skin of the patient |
| 12/02/2004 | US20040242587 Pyrrolo[1,2-b]pyridazine compounds |
| 12/02/2004 | US20040242586 gamma-aminobutyric acid receptor ligands, prepared by reacting [2-(2-(trimethylsilanyl)ethoxymethyl)-2H-[1,2,4]triazol-3-yl]methanol and 7-tert-butyl-6-chloro-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine, then deprotecting, to form drugs used as anticonvulsants and anxiolytic agents |
| 12/02/2004 | US20040242584 Muscarinic agonists |
| 12/02/2004 | US20040242582 diagnostic agent comprising a contrast agent for use in medical imaging conjugated with non-peptide folic acid analog |
| 12/02/2004 | US20040242579 Protective coatings; drugs, cosmetics, veterinary medicine; a diaminotriazine compound |
| 12/02/2004 | US20040242578 Pyrimidineamines as angiogenesis modulators |
| 12/02/2004 | US20040242577 N-methyl 2-morpholine-4-carbonyl or sulfonyl substituted; for example: 2-{[4-(3,4-dichlorophenoxy)piperidin-1-yl]methyl}morpholine; useful for treating asthma and/or rhinitis |
| 12/02/2004 | US20040242576 Urea substituted benzothiazoles |
| 12/02/2004 | US20040242575 for use with various disorders including sleep disorders; depression; cardiovascular disorders; pain; neurodegenerative disorders; psychiatric disorders etc. |
| 12/02/2004 | US20040242574 Anticancer agents; antiarthritic agents |
| 12/02/2004 | US20040242573 Novel compounds |
| 12/02/2004 | US20040242571 Novel benzothiazine derivatives, their preparation and use |
| 12/02/2004 | US20040242570 Conjugated psychotropic drugs and uses thereof |
| 12/02/2004 | US20040242568 Dipeptidyl peptidase inhibitors |
| 12/02/2004 | US20040242567 alone or in combination with a diuretic agent; diabetic nephropathy |
| 12/02/2004 | US20040242566 Dipeptidyl peptidase inhibitors |
| 12/02/2004 | US20040242565 Medicinal composition for prevention of or treatment for cerebrovascular disorder and cardiopathy |
| 12/02/2004 | US20040242564 1,2,3,4-tetrahydroisoquinolines derivatives |
| 12/02/2004 | US20040242561 Compound for use as tool in human disgnostics and therapeutics; greater tissue selectivity, increased efficacy, reduced side effects and a more favorable duration of action |
| 12/02/2004 | US20040242560 Process for synthesizing heterocyclic compounds |
| 12/02/2004 | US20040242558 Pyridylether derivatives, their preparation and use |
| 12/02/2004 | US20040242555 high dosage regimen delivered from a modified release formulation such as multilayer tablets |
| 12/02/2004 | US20040242553 Drugs to improve synaptic transmission |
| 12/02/2004 | US20040242552 New use of antimineralocorticoid compounds against narcotic withdrawal syndrome |
| 12/02/2004 | US20040242551 Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases |
| 12/02/2004 | US20040242550 kits containing a plurality of daily hormone units for use as antifertility agents; administering in two alternating consecutive phases of estrogenic and progestogenic phase; side effect reduction |
| 12/02/2004 | US20040242549 Neuroactive 13, 24-cyclo-18, 21-dinorcholanes and structurally related pentacyclic steroids |
| 12/02/2004 | US20040242548 Substituted tetracycline compounds for the treatment of malaria |
| 12/02/2004 | US20040242547 Arylazo-substituted imidazole for the treatment of stress urinary incontinence |
| 12/02/2004 | US20040242546 Compositions and method for treating infection in cattle and swine |
| 12/02/2004 | US20040242545 Remedy for glaucoma comprising as the active ingredient compound having p13 kinase inhibitory effect |
| 12/02/2004 | US20040242544 Stabilized derivatives of ascorbic acid-3-phosphate |
| 12/02/2004 | US20040242543 mixtures of antiprotozoa, antiemetic and antidiarrhea agents, used for prophylaxis of leishmaniasis |
| 12/02/2004 | US20040242542 Compositions and methods for inducing CD81 dependent antiproliferation and for treating hepatitis C and other disorders |
| 12/02/2004 | US20040242541 killing insects such as lice, ticks or fleas by applying low surface tension lubricants; topical |
| 12/02/2004 | US20040242539 Method of enhancing lysosomal alpha-galactosidase A |
| 12/02/2004 | US20040242538 Method to improve complexation efficacy and produce high-energy cylodextrincomplexes |
| 12/02/2004 | US20040242536 controlled-release mixtures of plant extracts, gelation polymers and drugs such as ximelagatran, used for prophylaxis of cardiovascular disorders |
| 12/02/2004 | US20040242535 mixtures of gellan gum, hyaluronic acids, antiseptics, fungicides or bactericides in the form of sprays, that form gels when applied to injuries |
| 12/02/2004 | US20040242534 Lyophilized powder of lentinan and the process of preparation thereof |
| 12/02/2004 | US20040242533 such as 5-iodo-O6-5'-cyclo-5,6-dihydro-3'-azido-3'-deoxythymidine for prophylaxis or diagnosis of viral diseases caused by hepatitis virus, herpes viruses such as Epstein-Barr virus |
| 12/02/2004 | US20040242532 Drug screening for and use of enzyme inhibitors of ADP-glucose pyrophosphorylase and glycogen synthase; adenosine alpha -P-boranodiphosphoglucose; bactericides |
| 12/02/2004 | US20040242531 Adenosine A1 Receptor Agonists; antiarrhythmia agents; oral, parenteral or transdermal administration up to four times daily |
| 12/02/2004 | US20040242530 2'-hydroxyl protecting groups or 2'-modification in the synthesis of RNA; protected nucleotides are easily handled during oligonucleotide synthesis; minimal degradation; deblocking under mild acidic conditions |
| 12/02/2004 | US20040242526 Disruption of the REG pathway |
| 12/02/2004 | US20040242525 Method for promoting gonadal growth in an animal |
| 12/02/2004 | US20040242523 Combination chemotherapy using a tumor necrosis factor-alpha expression construct and doxorubicin, cyclophosphamide, 5-fluorouracil, taxol or gemcitabine; lower dosages, decreased toxicity |
| 12/02/2004 | US20040242516 Antisense modulation of apolipoprotein(a) expression |
| 12/02/2004 | US20040242515 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy home-ostasis |
| 12/02/2004 | US20040242514 Xenogenic oligo or/and polyribonucleotides as agents for the treatment of malignant tumours |
| 12/02/2004 | US20040242509 Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate |
| 12/02/2004 | US20040242508 Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing the same |
| 12/02/2004 | US20040242507 Topical formulations of a lipophilic anthracycline with a second active ingredient and carrier; antiproliferative agents for skin and mucus membrane disorders; side effect reduction in psoriasis treatment with valrubicin |
| 12/02/2004 | US20040242506 Formed from paroxetine hydrochloride and ammonium glycyrrhyzinate by precipitation, spray, vacuum or freeze drying, or evaporation to glass; solid or oil; masks the bitter taste of paroxetine and has a distinctive licorice flavor; antidepressants; Parkinson's disease |
| 12/02/2004 | US20040242505 Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent |
| 12/02/2004 | US20040242504 Novel composition and method for the treatment of hypertension |
| 12/02/2004 | US20040242503 Compositions comprising blockers of l-dopa renal cell transfer for the treatment of parkinson's disease |
| 12/02/2004 | US20040242502 Semi-synthetic saponin analogs with carrier and immune stimulatory activities for DNA and RNA vaccines |
| 12/02/2004 | US20040242501 Spermicidal and virucidal properties of various forms of sophorolipids |
| 12/02/2004 | US20040242500 Administering stilbene derivatives such as tetramethoxy-stilbene or resveratrol |
| 12/02/2004 | US20040242499 For example, N-[2- beta -D-galactopyranosylthio-1-(tetradecylcarbamoyl)ethyl]octadecanoylamide or N-[2-( beta -D-galactopyranosyloxy)ethyl]octadecanoylamide; for treating rough skin |
| 12/02/2004 | US20040242498 CXCR3 antagonists |
| 12/02/2004 | US20040242497 Ammonium glycyrrhyzinate masks the bitter taste of paroxetine hydrochloride and has a distinctive licorice flavor; dispersable powders or tablets; antidepressants; Parkinson's disease |
| 12/02/2004 | US20040242493 Neurotensin active 2,3,diaryl-pyrazolidine derivatives |
| 12/02/2004 | US20040242491 For use in the treatment of gout and related symptoms or in the amelioration of symptoms related to a high level of uric acid such as muscle spasm, localized swelling, inflammation, joint pains, muscle fatigue, or as a dietary supplement |
| 12/02/2004 | US20040242485 Compositions and methods for the amelioration of leptin resistance |
| 12/02/2004 | US20040242483 Molecules, compositions, methods and kits for applications associated with flaviviruses |
| 12/02/2004 | US20040242481 Use of hmgb1 for the activation of dendritic cells |
| 12/02/2004 | US20040242480 Method for treating coumarin-induced hemorrhage |
| 12/02/2004 | US20040242478 5-cnac as oral delivery agent for parathyroid hormone fragments |
| 12/02/2004 | US20040242463 Compositions for stabilizing oxygen-labile species |
| 12/02/2004 | US20040242459 Method for treating inflammatory diseases by administering a ppar-delta agonist |
| 12/02/2004 | US20040242457 Use of anti-glaucoma drugs to treat visual defects associated with the use of a GABAergic agent |
| 12/02/2004 | US20040242454 System and method for micro-dose, multiple drug therapy |
| 12/02/2004 | US20040242452 For effecting mental control through psycho-sedation or psycho-stimulation |
| 12/02/2004 | US20040242416 Compositions and methods for intracellular delivery |
| 12/02/2004 | US20040241844 Oligonucleotides for controlling expression of c-reactive protein for use in treatment of infection, autoimmune, diabetic or inflammatory disease |
| 12/02/2004 | US20040241840 Compositions for therapy |
| 12/02/2004 | US20040241839 Nutrient broth comprising lysophosphatidic acid receptor containing neuronal cells, nestin and tubulin for use in propagating neurons, oligodendrocytes and astrocytes; tissue engineering and organ development; remodeling nervous system tissue |
| 12/02/2004 | US20040241815 Process for producing 1,4-dihysdroxy-2-naphthoic acid |
| 12/02/2004 | US20040241803 25 human secreted proteins |
| 12/02/2004 | US20040241781 Using benzodiazepine derivatives to treat and prevent defects in programed cell death, autoimmune, inflammatory and cell proliferative diseases |
| 12/02/2004 | US20040241731 Methods of producing nucleic acid ligands |
| 12/02/2004 | US20040241705 Method of determining a chemotherapeutic regimen based on glutathione-s-transferase pi |
| 12/02/2004 | US20040241682 Cancer |
| 12/02/2004 | US20040241261 Synergistic combination of natural antioxidants contained in the extracts of grape seeds, vine leaves, and grape skins; used in particular for counteracting ageing of the skin. |
| 12/02/2004 | US20040241260 Menopause therapy; mixture of flavonoids and Lactobacillus |
| 12/02/2004 | US20040241256 Containing phenylalanine or hydrocinnamic acid, s-adenosylmethionine, and optionally L-tryptophine or glutathione; for treating arthritis and pain |
| 12/02/2004 | US20040241249 Prepared by ketone extraction of krill; evaporating ketone in liquid product; 2nd extraction of the solids in the product with an alcohol or acetate solvent to form a soluble lipid fraction; separating liquids and solids in 2nd product and evaporating solvent from liquid fraction; recovering solids |
| 12/02/2004 | US20040241248 Crosslinking the carboxylic acid groups in a glycosaiminoglycan with a primary amine in a lipid to form particles that can be used to encapsulate various drugs, especially chemotherapeutic agents |
| 12/02/2004 | US20040241245 Compositions and methods for treatment of premature ejaculation |
| 12/02/2004 | US20040241244 Neuronal growth enhancement by prostaglandin compositions and methods |
| 12/02/2004 | US20040241243 Angiogenesis promotion by prostaglandin compositions and methods |
| 12/02/2004 | US20040241240 A copolymer of N-vinyl-2-pyrrolidone with e.g., ethylhexyl acrylate and 1,6-hexanediol diacrylate, enhances absorption of a hardly soluble drug such as one having an ergoline skeleton, e.g., a pergolide or a bromocriptine; improved skin permeability |